MAH

Greystone Provides $11.9 Million in Fannie Mae Financing for the Acquisition of Affordable Seniors Housing in Tavares, Florida

Retrieved on: 
Wednesday, November 30, 2022

NEW YORK, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Greystone , a leading national commercial real estate finance company, has provided an $11,916,000 Fannie Mae Multifamily Affordable Housing (MAH) loan for the acquisition of a senior living community in Tavares, Florida.

Key Points: 
  • NEW YORK, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Greystone , a leading national commercial real estate finance company, has provided an $11,916,000 Fannie Mae Multifamily Affordable Housing (MAH) loan for the acquisition of a senior living community in Tavares, Florida.
  • Constructed in 2006, Lake Point Senior Apartments in Lake County is a 160-unit, LIHTC, age-restricted, 3-story elevatored apartment complex.
  • Greystone has substantial multifamily lending proficiency and expertise, particularly in the affordable housing space, said Mr. King.
  • Loans are offered through Greystone Servicing Company LLC, Greystone Funding Company LLC and/or other Greystone affiliates.

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

Retrieved on: 
Friday, November 11, 2022

Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.

Key Points: 
  • Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.
  • Commenting on Novotech's experience, Chief Commercial Officer Barry Murphy said the right drug development pathway supports investor attraction and a successful clinical program.
  • Strategies for an East-West MRCT include:
    - Companies should engage with the US FDA and NMPA early to confirm guidance on their clinical roadmap.
  • Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases.

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

Retrieved on: 
Friday, November 11, 2022

Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.

Key Points: 
  • Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.
  • Commenting on Novotechs experience, Chief Commercial Officer Barry Murphy said the right drug development pathway supports investor attraction and a successful clinical program.
  • Strategies for an East-West MRCT include:
    Companies should engage with the US FDA and NMPA early to confirm guidance on their clinical roadmap.
  • In Asia Pacific Novotech has more than 50 Leading Site Partnership agreements with major medical research institutions which delivers exclusive benefits for sponsors.

China Pharmaceutical Contract Manufacturing Market Report 2022: Increasing Prevalence of Non-Communicable Diseases Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 1, 2022

The China pharmaceutical contract manufacturing market is growing at a CAGR of around 12.1% during the forecast period.

Key Points: 
  • The China pharmaceutical contract manufacturing market is growing at a CAGR of around 12.1% during the forecast period.
  • The major factor that drives the growth of the market includes the major companies in the pharmaceutical contract manufacturing market are expanding their manufacturing capacity in China.
  • It shows the efforts of China contract manufacturers towards drug development, which in turn is projected to increase the China pharmaceutical contract manufacturing market.
  • Among product types, the API segment is estimated to be the dominating segment in the China pharmaceutical contract manufacturing market.

Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper

Retrieved on: 
Sunday, October 30, 2022

The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.

Key Points: 
  • The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.
  • Novotechs Vice President, Global Head of Clinical Services Dr. Yooni Kim said:
    China presents exceptional clinical opportunities with vast populations and word-class research facilities and KOLs.
  • This concise analysis of the pathway to USFDA approval expertly informs clinical stage biotechs about the China research benefits and how to manage any challenges.
  • The report details the regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful USFDA approval pathway.

Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper

Retrieved on: 
Tuesday, October 25, 2022

The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.

Key Points: 
  • The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.
  • Novotech's Vice President, Global Head of Clinical Services Dr. Yooni Kim said: "China presents exceptional clinical opportunities with vast populations and word-class research facilities and KOLs.
  • This concise analysis of the pathway to USFDA approval expertly informs clinical stage biotechs about the China research benefits and how to manage any challenges.
  • The report details the regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful USFDA approval pathway.

Advanced Pharmacovigilance Auditing and Inspections Course (January 12-13, 2023) - ResearchAndMarkets.com

Retrieved on: 
Monday, October 17, 2022

The "Advanced Pharmacovigilance Auditing and Inspections Course" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Advanced Pharmacovigilance Auditing and Inspections Course" training has been added to ResearchAndMarkets.com's offering.
  • It includes an audit of the pharmacovigilance system which is covered by the quality system.
  • The PV Audit Strategy Plan is used to prepare the PV audit program, i.e.
  • The course will focus on the design of the PV audit strategy, identification of the PV processes and entities subject to PV audit (define the PV audit universe), development of risk assessment methodology, development of procedures/tools to monitor PV processes and activities, and implementation of the PV audit strategy plan.

Global Lithium-ion Battery Market Growth Rate, Key Players, Demands, Size, Share, Capacity, Voltage, Application and Forecasts to 2031 - ReportsnReports

Retrieved on: 
Tuesday, September 13, 2022

PUNE, India, Sept. 13, 2022 /PRNewswire/ -- ReportsnReports added a Global Lithium-ion Battery Market In-Depth Analysis and Forecast to 2031 report to its online research database.

Key Points: 
  • PUNE, India, Sept. 13, 2022 /PRNewswire/ -- ReportsnReports added a Global Lithium-ion Battery Market In-Depth Analysis and Forecast to 2031 report to its online research database.
  • Major players operating in the lithium-ion battery market include LG Chem (South Korea), SAMSUNG SDI CO. LTD. (South Korea), Contemporary Amperex Technology Co., Limited.
  • The Asia Pacific region is expected to hold the largest market growth rate of the lithium-ion battery market during the forecast period.
  • Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Global Lithium-ion Battery Market Growth Rate, Key Players, Demands, Size, Share, Capacity, Voltage, Application and Forecasts to 2031 - ReportsnReports

Retrieved on: 
Tuesday, September 13, 2022

PUNE, India, Sept. 13, 2022 /PRNewswire/ -- ReportsnReports added a Global Lithium-ion Battery Market In-Depth Analysis and Forecast to 2031 report to its online research database.

Key Points: 
  • PUNE, India, Sept. 13, 2022 /PRNewswire/ -- ReportsnReports added a Global Lithium-ion Battery Market In-Depth Analysis and Forecast to 2031 report to its online research database.
  • Major players operating in the lithium-ion battery market include LG Chem (South Korea), SAMSUNG SDI CO. LTD. (South Korea), Contemporary Amperex Technology Co., Limited.
  • The Asia Pacific region is expected to hold the largest market growth rate of the lithium-ion battery market during the forecast period.
  • Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Two Day Advanced Pharmacovigilance Auditing and Inspections Course (September 15-16, 2022)

Retrieved on: 
Monday, September 12, 2022

DUBLIN, Sept. 12, 2022 /PRNewswire/ --Final days to register for the "Advanced Pharmacovigilance Auditing and Inspections Course" that has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 12, 2022 /PRNewswire/ --Final days to register for the "Advanced Pharmacovigilance Auditing and Inspections Course" that has been added to ResearchAndMarkets.com's offering.
  • It includes audit of the pharmacovigilance system which is covered by the quality system.
  • The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis.
  • The PV Audit Strategy Plan is used to prepare the PV audit program, i.e.